These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 28924)

  • 1. Binding of iophenoxate and iopanoate to human serum albumin.
    Mudge GH; Desbiens N; Stibitz GR
    Drug Metab Dispos; 1978; 6(4):432-9. PubMed ID: 28924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition for binding to multiple sites of human serum albumin for cholecystographic agents and sulfobromophthalein.
    Mudge GH; Stibitz GR; Robinson MS; Gemborys MW
    Drug Metab Dispos; 1978; 6(4):440-51. PubMed ID: 28925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of iopanoic and iophenoxic acids with human serum albumin.
    Fehske KJ; Müller WE
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):119-27. PubMed ID: 625581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phenobarbital and taurocholate on biliary excretion of iopanoate and iophenoxate in the rat.
    Cooke WJ; Berndt WO; Mudge GH
    J Pharmacol Exp Ther; 1973 Oct; 187(1):158-68. PubMed ID: 4746323
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholecystographic agents and drug binding to plasma albumin.
    Mudge GH
    Invest Radiol; 1980; 15(6 Suppl):S102-8. PubMed ID: 7203911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of choleretics on biliary and urinary excretion of cholecystographic agents.
    Cooke WJ; Mudge GH
    Invest Radiol; 1975; 10(3):189-96. PubMed ID: 236988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion of iopanoate glucuronide by the rat.
    Cooke WJ; Cooke L
    Drug Metab Dispos; 1977; 5(4):368-76. PubMed ID: 19216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of drug binding to human serum albumin by cholecystographic agents.
    Bertucci C; Cimitan S
    Farmaco; 2003 Sep; 58(9):901-8. PubMed ID: 13679185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin.
    Sudlow G; Birkett DJ; Wade DN
    Mol Pharmacol; 1973 Sep; 9(5):649-57. PubMed ID: 4788159
    [No Abstract]   [Full Text] [Related]  

  • 11. The interactions between iophenoxic acid, iopanoic acid, bilirubin and human serum albumin as studied by fluorescence and Sephadex gel filtration.
    Birkett DJ; Kapitulnik J
    Clin Chim Acta; 1976 Sep; 71(2):129-35. PubMed ID: 963887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic analysis reveals the structural basis of the high-affinity binding of iophenoxic acid to human serum albumin.
    Ryan AJ; Chung CW; Curry S
    BMC Struct Biol; 2011 Apr; 11():18. PubMed ID: 21501503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.
    Pardridge WM; Mietus LJ
    J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of two anthranilic acid derivatives to human albumin, erythrocytes, and lipoproteins: evidence for glafenic acid high affinity binding.
    Albengres E; Urien S; Riant P; Marcel GA; Tillement JP
    Mol Pharmacol; 1987 Mar; 31(3):294-300. PubMed ID: 2882410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Competitive interrelations between bilirubin and x-ray contrast agents in binding with human serum albumin].
    Shimanovskiĭ NL; Kuriashkin IV
    Farmakol Toksikol; 1986; 49(2):52-5. PubMed ID: 3709775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake of iopanoic acid and its glucuronide conjugate by rat hepatocytes in primary culture.
    Barnhart JL; Witt BL
    Proc Soc Exp Biol Med; 1983 Sep; 173(4):506-11. PubMed ID: 6889314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saturation kinetics of iopanoate in the dog.
    Nelson JA; Staubus AE; Riegelman S
    Invest Radiol; 1975; 10(4):371-7. PubMed ID: 1184327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.